NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
- Status
- WITHDRAWN
- Phase
- PHASE2
Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study of Screening Brain MRIs in Stage IV Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Asian Multicenter Prospective Study of ctDNA Sequencing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2